Navigation Links
3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer
Date:2/9/2009

SHENYANG, China, Feb. 9 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has appointed Mr. Bo Tan as Chief Financial Officer, effective February 1, 2009. Since joining 3SBio in October 2008, Mr. Tan has been acting as the financial advisor for the company, providing advice on the company's capital market initiatives and overseeing the company's treasury functions.

Dr. Jing Lou, Chief Executive Officer of 3SBio, commented, "I am delighted to name Bo as our CFO, given both his recent contributions to 3SBio as financial advisor and the broad wealth of experience he brings, as reflected by his previous roles in the financial services industry and pharmaceutical industry. I strongly believe that his skills and experience will further benefit our company during an important time of our development."

Mr. Tan, 36, has extensive experience within the financial and pharmaceutical industries, having worked across private equity, equity research and commercial practice. Previously, he has served as the Executive Director and a member of Investment Committee for Bohai Industrial Fund Management Company, a private equity fund in China. Earlier in his career, he spent six years in the pharmaceutical industry with Eli Lilly & Company and EMD Pharmaceuticals, Inc in North America and went on to serve as a China healthcare and consumer analyst at Lehman Brothers Asia and Macquarie Securities in Hong Kong.

"I am honored to be appointed as the CFO of 3SBio and I look forward to continuing to work closely with Dr. Lou and my other colleagues," remarked Mr. Tan. "Our company is in the middle of a critical and exciting stage of development, and I believe that my experiences will be able to contribute to what is an already strong management team."

Mr. Tan received his MBA degree from Thunderbird School of International Management, an MA degree in economics from the University of Connecticut and a BA degree in economics from Renmin University of China. Mr. Tan is also a CFA (Chartered Financial Analyst).

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at: http://www.3sbio.com .

    For more information, please contact:

     Bo Tan, CFO
     3SBio Inc.
     Tel: +86-24-2581-1820

     Investor Relations (China):
     Peter Schmidt
     FD Asia
     Tel: +86-10-8591-1953

     Investor Relations (US):
     Evan Smith or John Capodanno
     FD US
     Tel: +1-212-850-5600

'/>"/>
SOURCE 3SBio Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. 3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference
2. 3SBio Inc. Announces Third Quarter 2008 Results
3. 3SBio Inc. Files for SFDA Approval of NuLeusin
4. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
5. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
6. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
7. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
8. 3SBio Inc. Announces Results of Annual General Meeting
9. 3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. 3SBio Inc. to Hold Annual General Meeting
11. 3SBio Inc. Announces Second Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... WARSAW, Ind. , May 23, 2016 Zimmer ... in musculoskeletal healthcare, today announced that its Board of Directors ... stockholders for the second quarter of 2016. ... on or about July 29, 2016 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
(Date:5/23/2016)... ... 23, 2016 , ... Foresight Institute , a leading ... for the 2015 Foresight Institute Feynman Prizes. , These prestigious prizes, named ... for experiment and the other for theory in nanotechnology. Prof. Markus J. Buehler, ...
(Date:5/20/2016)... ... 20, 2016 , ... Korean researchers say Manumycin A triggers apoptosis, or natural ... to treat the disease. Surviving Mesothelioma has just posted an article on the new ... institutions based their mesothelioma study on the fact the Manumycin A, a derivative of ...
(Date:5/19/2016)... , May 19, 2016 There ... fully recover given the relentless pressures in pricing and ... in the investors circle though - numerous opportunities are ... of today,s session, ActiveWallSt.com,s presents four names in this ... Vitae Pharmaceuticals Inc. (NASDAQ: VTAE ), Anthera ...
Breaking Biology Technology:
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/21/2016)... , March 22, 2016 ... with passcodes for superior security   ... leading provider of secure digital communications services, today announced ... technology and offer enterprise customers, particularly those in the ... recognition and voice authentication within a mobile app, alongside, ...
(Date:3/15/2016)... --> --> ... Research "Digital Door Lock Systems Market - Global Industry Analysis, ... global digital door lock systems market in terms of revenue ... forecast to grow at a CAGR of 31.8% during the ... enterprises (MSMEs) across the world and high industrial activity driving ...
Breaking Biology News(10 mins):